Do any of your patients have Early Menopause? – Clinical Trial

Categories:

A study to prevent bone loss and restore sexual function in women with early menopause

đź’ˇHelp researchers learn more about a new potential therapy for early menopause.

đź’ˇQualify to take part and you could receive study-related care at no cost, as well as compensation.

 

Patients Register Here

 

 

As many as 10 in every 100 Australian women go through menopause before the age of 45 years. This loss of ovarian function is called early menopause.

Women with early menopause do not produce sufficient estrogen or testosterone necessary for good bone health. They experience progressive bone loss, increasing their risk of osteoporosis (weakened bone strength) and fractures at a young age. Despite adequate estrogen replacement many women with early menopause also experience sexual dysfunction.

There is some evidence that the addition of testosterone to estrogen replacement therapy
might prevent bone loss and restore sexual function in women with early menopause, but convincing evidence from well conducted trials is needed.

The purpose of this research is to determine whether the use of testosterone therapy, in a
dose we have shown restores testosterone levels to those of premenopausal women,
prevents bone loss and improves sexual function in women with early menopause who are taking the standard dose of estrogen.

This is a 12-month study using topical testosterone cream applied to the skin on women aged under 45 years with early menopause
Your participation would involve 4-5 visits with blood collection and bone density scans

 

This study is approved by Monash University Human Research Ethics Committee.

 

 

Latest News


Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido

International Society For Sexual Medicine Mindfulness May Help Lower Sexual Distress in Older Women With Low Libido    

NEW IMS Symposium with Dr James Simon & Sharon Parish NEW IMS Symposium with Dr James Simon & Sharon Parish

Sexual Health and Treatment for Women: Fact, Fiction, the Future. At the International Menopause Society’s 19th World Congress on Menopause to be held 19th – 22nd October 2024 in… Continue Reading →

INTERNATIONAL RECOGNITION PROCEDURE OFFERS HOPE FOR UK’S POSTMENOPAUSAL WOMEN. INTERNATIONAL RECOGNITION PROCEDURE OFFERS HOPE FOR UK’S POSTMENOPAUSAL WOMEN.

Hypoactive Sexual Desire Dysfunction (HSDD) Perth, Australia: Lawley Pharmaceuticals, via UK-based commercial partner, Andro Pharmaceuticals Ltd, today submitted a Marketing Authorisation Application (MAA) for… Continue Reading →